The announcement by AstroZeneca follows a growing trend of companies pledging to invest in pharmaceutical manufacturing on ...

A further ten million Oxford-AstraZeneca vaccines have been sent by the UK to COVAX, with 10 million more due to be delivered in the coming weeks to some of the world's most vulnerable people.

The UK donated over 4 million doses of the University of Oxford-AstraZeneca vaccine, made by Oxford Bio-medica in Oxford and packaged in Wrexham, North Wales, to Bangladesh through the COVAX ...

Britain's Oxford Biomedica said on Friday it had signed a new three-year agreement to potentially make AstraZeneca's COVID-19 vaccine beyond 2022, but no volumes were defined in an indication of ...

(RTTNews) - Oxford Biomedica plc (OXB.L) said that it has signed a new three year master services & development agreement with AstraZeneca UK Ltd which would facilitate potential future ...

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 (as it forms part of ...

A three-dose course of AstraZeneca's COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an ...

AstraZeneca said Monday that late-stage trials showed that its COVID-19 vaccine with Oxford University was up to 90% effective in preventing disease.